These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18817677)

  • 21. The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents.
    Kim SW; Mintz GS; Hong YJ; Pakala R; Park KS; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ
    Am J Cardiol; 2008 Nov; 102(9):1182-6. PubMed ID: 18940288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries.
    Hoffmann R; Mintz GS; Popma JJ; Satler LF; Pichard AD; Kent KM; Walsh C; Mackell P; Leon MB
    J Am Coll Cardiol; 1996 Nov; 28(5):1134-9. PubMed ID: 8890806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial.
    Tsuchida K; Serruys PW; Bruining N; Dudek D; Drzewiecki J; Banning AP; Zmudka K; Schiele F; Zhou Z; Rademaker TA; van Es GA; Koglin J; Russell ME; Colombo A
    Am J Cardiol; 2007 Mar; 99(5):607-15. PubMed ID: 17317358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):107-9. PubMed ID: 15619404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
    Togni M; Räber L; Cocchia R; Wenaweser P; Cook S; Windecker S; Meier B; Hess OM
    Int J Cardiol; 2007 Aug; 120(2):212-20. PubMed ID: 17234280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
    Büllesfeld L; Gerckens U; Müller R; Grube E
    Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
    Kim JW; Suh SY; Choi CU; Na JO; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ
    JACC Cardiovasc Interv; 2008 Feb; 1(1):65-71. PubMed ID: 19393147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lumen narrowing within coronary stents on proximal and distal vessel segments following bare metal stent implantation.
    Kaneda H; Ako J; Kataoka T; Miyazawa A; Terashima M; Ikeno F; Sonoda S; Shimada Y; Morino Y; Honda Y; Yock PG; Fitzgerald PJ
    Am J Cardiol; 2005 Aug; 96(3):376-8. PubMed ID: 16054461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.
    Aoki J; Colombo A; Dudek D; Banning AP; Drzewiecki J; Zmudka K; Schiele F; Russell ME; Koglin J; Serruys PW;
    Circulation; 2005 Dec; 112(25):3876-83. PubMed ID: 16344384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
    Mintz GS; Tinana A; Hong MK; Lee CW; Kim JJ; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Circulation; 2003 Sep; 108(11):1295-8. PubMed ID: 12952833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.
    Petronio AS; De Carlo M; Branchitta G; Papini B; Ciabatti N; Gistri R; Cortese B; Gherarducci G; Barsotti A
    J Am Coll Cardiol; 2007 Feb; 49(5):539-46. PubMed ID: 17276176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of paclitaxel-eluting stents on restenosis].
    Kurşaklioğlu H; Köz C; Iyisoy A; Ide T; Yildirim V; Töre HF; Işik E; Demirtaş E
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):18-23. PubMed ID: 16524795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of vessel response following sirolimus-eluting stent implantation as assessed by serial 3-D intravascular ultrasound study.
    Waseda K; Ako J; Shimada Y; Morino Y; Tsujino I; Hongo Y; Sudhir K; Yock PG; Fitzgerald PJ; Honda Y
    J Invasive Cardiol; 2007 Apr; 19(4):171-3. PubMed ID: 17404402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J
    J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravascular ultrasound findings in patients with restenosis of sirolimus- and paclitaxel-eluting stents.
    Ohlmann P; Mintz GS; Kim SW; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ
    Int J Cardiol; 2008 Mar; 125(1):11-5. PubMed ID: 17442432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peri-stent reference segment plaque burden is associated with disease progression in saphenous vein grafts (a serial intravascular ultrasound assessment).
    Hong YJ; Mintz GS; Kim SW; Okabe T; Lu L; Bui AB; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ
    Am J Cardiol; 2007 Oct; 100(8):1233-8. PubMed ID: 17920363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.
    Wilson GJ; Nakazawa G; Schwartz RS; Huibregtse B; Poff B; Herbst TJ; Baim DS; Virmani R
    Circulation; 2009 Jul; 120(2):141-9, 1-2. PubMed ID: 19564562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.